This article is a correction to:
Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
Yangyang Guo
Kenan Cen
Qiaoqiao Chen4,5†
Kai Hong- 1Department of Thyroid and Breast Surgery, Ningbo First Hospital, Ningbo, Zhejiang, China
- 2Department of Thyroid and Breast Surgery, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang, China
- 3Department of Geriatrics Medicine, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China
- 4Reproductive Medicine Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
- 5Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
A corrigendum on
Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
by Guo Y, Cen K, Chen Q, Dai Y, Mai Y, Hong K, (2023) 13:891233. doi: 10.3389/fimmu.2023.1128390
In the published article, there was an error in the author list, The incorrect author list appeared as “Kai Hong 1,2†, Kenan Cen 3†,Qiaoqiao Chen 4,5†, Ying Dai3†, Yifeng Mai3* and Yangyang Guo1,2* “. The corrected author list appears below:
Yangyang Guo 1,2†, Kenan Cen3†, Qiaoqiao Chen4,5†, Ying Dai3†, Yifeng Mai 3* and Kai Hong1,2*
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: thyroid cancer, cellular senescence, tumor microenvironment, signature, immunotherapy, prognosis
Citation: Guo Y, Cen K, Chen Q, Dai Y, Mai Y and Hong K (2023) Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Front. Immunol. 14:1229541. doi: 10.3389/fimmu.2023.1229541
Received: 26 May 2023; Accepted: 30 May 2023;
Published: 05 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Guo, Cen, Chen, Dai, Mai and Hong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yifeng Mai, fymaiyifeng@nbu.edu.cn; Kai Hong, hongkai0629@163.com
†These authors have contributed equally to this work